- Home
- AZI vs PBYI Comparison
AZI vs PBYI Comparison
Compare AZI & PBYI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | AZI | PBYI |
|---|---|---|
| Founded | 2010 | 2010 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2M | 263.4M |
| IPO Year | 2024 | N/A |
Fundamental Metrics
Financial Performance| Metric | AZI | PBYI |
|---|---|---|
| Price | $3.21 | $5.92 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $7.00 |
| AVG Volume (30 Days) | ★ 9.2M | 393.2K |
| Earning Date | 01-28-2026 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 59.87 |
| EPS | N/A | ★ 0.74 |
| Revenue | $156,466,000.00 | ★ $211,995,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $7.94 |
| Revenue Growth | ★ 32.90 | N/A |
| 52 Week Low | $1.33 | $2.58 |
| 52 Week High | $69.00 | $6.12 |
Technical Indicators
Market Signals| Indicator | AZI | PBYI |
|---|---|---|
| Relative Strength Index (RSI) | 84.26 | 62.10 |
| Support Level | $2.82 | $5.51 |
| Resistance Level | $4.39 | $5.99 |
| Average True Range (ATR) | 0.40 | 0.22 |
| MACD | 0.29 | 0.03 |
| Stochastic Oscillator | 72.46 | 81.59 |
Price Performance
Historical ComparisonAbout AZI Autozi Internet Technology (Global) Ltd. Class A Ordinary Shares
Autozi Internet Technology (Global) Ltd provides high-quality, affordable, and professional one-stop automotive products and services through online and offline channels in China. Leveraging its online supply chain cloud platform, SaaS platforms, and the network of MBS stores, It has established an ecosystem of lifecycle automotive services by connecting automotive manufacturers, auto parts manufacturers, and insurance companies with MBS stores and various automotive owners. Its business segments include new car sales, auto parts and auto accessories sales, and automotive insurance-related services. The majority of revenue is from the new car sales segment, and auto parts & auto accessories sales.
About PBYI Puma Biotechnology Inc
Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes inventive products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also it develops alisertib. Alisertib is a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis resulting into apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.